Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: Continuous increasing of ciprofloxacin-resistant isolates

International Journal of Antimicrobial Agents

Volumn 24, Issue SUPPL. 1, 2004, Pages 15-22

  Tanaka, Masatoshi ^a   Nakayama, Hiroshi ^b   Notomi, Takashi ^a   Irie, Shin Ichiro ^a   Tsunoda, Yuichi ^a   Okadome, Aya ^a   Saika, Takeshi ^c   Kobayashi, Intetsu ^c  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nakayama Urologic Clinic   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Auxotype; DNA gyrase; Neisseria gonorrhoeae; Resistance; Topoisomerase IV

Indexed keywords

AMINO ACID; ARGININE; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GATIFLOXACIN; LEVOFLOXACIN; PENICILLIN G; PROLINE; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; SITAFLOXACIN; SPECTINOMYCIN; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; EXPERIMENTAL TEST; GYRA GENE; JAPAN; MUTATIONAL ANALYSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PARC GENE; PLASMID; PRIORITY JOURNAL;

EID: 4444324639     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.005     Document Type: Conference Paper

References (16)

1. Tanaka M., Nakayama H., Haraoka M., Saika T., Kobayashi I., Naito S. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J. Clin. Microbiol. 38:2000;521-525
2. Tanaka M., Matsumoto T., Sakumoto M., et al. Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. Antimicrob. Agents Chemother. 42:1998;579-582
3. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A5. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
4. Catlin B.W. Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and use of growth requirements for gonococcal typing. J. Infect. Dis. 128:1973;178-194
5. Tapsall J.W. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun. Dis. Intell. 25:2001;274-276
6. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2002. Morb Mortal Wkly Rep 2002;51:RR-6.
7. The Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases in the United Kingdom. National guideline for the management of gonorrhoeae in adults. Sex Transm Inf 1999;75(Suppl 1):S13-15.
8. Dougherty T.J., Koller A.E., Tomasz A. Penicillin-binding proteins of penicillin-susceptible and intrinsically resistant Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 18:1980;730-737
9. Gill M.J., Simjee S., Al-Hattawi K., Robertson B.D., Easmon C.S., Ison C.A. Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob. Agents Chemother. 42:1998;2799-2803
10. Hagman K.E., Pan W., Spratt B.G., Balthazar J.T., Judd R.C., Shafer W.M. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology. 141:1995;611-622
11. Knapp J.S., Holmes K.K. Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements. J. Infect. Dis. 132:1975;204-208
12. Handsfield H.H., Sandstrom E.G., Knapp J.S., et al. Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N. Eng. J. Med. 306:1982;950-954
13. Noble R.C., Parekh M.C. Association of auxotypes of Neisseria gonorrhoeae and susceptibility to penicillin G, spectinomycin, tetracycline, cefaclor, cefoxitin, and moxalactam. Sex Transm. Dis. 10:1983;18-23
14. van Klingeren B., Ansink-Schipper M.C., Doornbos L., et al. Surveillance of the antibiotic susceptibility of non-penicillinase producing Neisseria gonorrhoeae in The Netherlands from 1983 to 1986. J. Antimicrob. Chemother. 21:1988;737-744
15. van Klingeren B., Ansink-Schipper M.C., Dessens-Kroon M., Verheuvel M. Relationship between auxotype, plasmid pattern and susceptibility to antibiotics in penicillinase-producing Neisseria gonorrhoeae. J. Antimicrob. Chemother. 16:1985;143-147
16. Belland R.J., Morrison S.G., Ison C.A., Huang W.M. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone- resistant isolates. Mol. Microbiol. 14:1994;371-380